![]() ![]() Shaheen’s Ensuring Timely Access to Generics Act would work to increase competition from generic drugs through better oversight of the Food and Drug Administration’s (FDA) citizen petition process. I urge Senate leadership to swiftly bring this bill to the floor for full consideration.” By holding bad actors who exploit the petition process accountable and increasing competition, we can bring more prescription drugs to market and drive down costs for Americans. "Members from both sides of the aisle are eager to find commonsense solutions to help curb these surging costs. ![]() I'm proud that my bipartisan legislation to reduce drug prices unanimously cleared a key committee hurdle today, bringing us one step closer towards realizing this goal," said Senator Shaheen, co-chair of the Senate Diabetes Caucus. "Addressing the soaring costs of prescription medications remains a pressing issue for Granite Staters. Shaheen reintroduced the Ensuring Timely Access to Generics Act with Senators Susan Collins (R-ME), Michael Bennet (D-CO), Marco Rubio (R-FL), Tammy Baldwin (D-WI) and Mike Braun (R-IN) earlier this year to increase competition for generic drugs by providing better oversight from the Food and Drug Administration (FDA), which would help to lower costs. Senator Jeanne Shaheen (D-NH), co-chair of the Senate Diabetes Caucus, announced that her bipartisan bill to lower Americans’ prescription drug costs unanimously cleared the Senate Committee on Health, Education, Labor and Pensions today. **The bipartisan legislation increases competition and brings generic drugs to market to lower costs** ![]() NEW: HELP Committee Unanimously Approves Shaheen-Led Bill to Lower Cost of Prescription Drugs, Bring Generic Medication to Market May 11, 2023 ![]()
0 Comments
Leave a Reply. |